Morgan Stanley 13D and 13G filings for NeuroPace, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-04 12:50 pm Purchase | 2024-12-31 | 13G | NeuroPace, Inc. NPCE | MORGAN STANLEY MS | 2,489,391 8.300% | 28,675 (+1.17%) | Filing |
| 2024-02-09 1:25 pm Purchase | 2023-12-31 | 13G | NeuroPace, Inc. NPCE | MORGAN STANLEY MS | 2,460,716 9.400% | 272,123 (+12.43%) | Filing |
| 2023-02-10 1:12 pm Purchase | 2022-12-30 | 13G | NeuroPace, Inc. NPCE | MORGAN STANLEY MS | 2,188,593 8.800% | 2,188,593 (New Position) | Filing |